Growth Metrics

Insulet (PODD) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -171.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -171.74%
Dec 31, 2025 -171.55%
Sep 30, 2025 -569.91%
Jun 30, 2025 -340.88%
Mar 31, 2025 558.38%
Dec 31, 2024 271.52%
Sep 30, 2024 190.94%
Jun 30, 2024 193.36%
Mar 31, 2024 192.18%
Dec 31, 2023 130.27%
Sep 30, 2023 40.21%
Jun 30, 2023 1,238.89%
Mar 31, 2023 33.62%
Dec 31, 2022 17.67%
Sep 30, 2022 350.00%
Jun 30, 2022 -94.90%
Mar 31, 2022 6.15%
Dec 31, 2021 -181.49%
Sep 30, 2021 -92.68%
Jun 30, 2021 -93.89%
Mar 31, 2021 -836.96%
Dec 31, 2020 137.14%
Sep 30, 2020 -80.96%
Jun 30, 2020 6,309.68%
Mar 31, 2020 -158.97%
Dec 31, 2019 -1,651.67%
Sep 30, 2019 3,217.89%
Jun 30, 2019 86.02%
Mar 31, 2019 122.57%
Dec 31, 2018 -107.02%
Sep 30, 2018 -133.91%
Jun 30, 2018 -2,320.73%
Mar 31, 2018 -12.96%
Dec 31, 2017 318.21%
Sep 30, 2017 -79.60%
Jun 30, 2017 92.36%
Mar 31, 2017 -444.09%
Dec 31, 2016 -243.47%
Sep 30, 2016 25,316.00%
Jun 30, 2016 -7,536.73%
Mar 31, 2016 -101.38%
Dec 31, 2015 -571.69%
Sep 30, 2015 101.89%
Jun 30, 2015 -101.57%
Mar 31, 2015 -35.79%
Dec 31, 2014 215.39%
Sep 30, 2014 -1,085.24%
Jun 30, 2014 939.63%
Mar 31, 2014 -104.53%
Dec 31, 2013 32.07%
Sep 30, 2013 144.19%
Jun 30, 2013 122.38%
Mar 31, 2013 929.04%
Dec 31, 2012 37.61%
Sep 30, 2012 -128.39%
Jun 30, 2012 -669.62%
Mar 31, 2012 -24.62%
Dec 31, 2011 -205.35%
Sep 30, 2011 79.27%